A 60-year-old man was seen in the hospital with a history of conjunctival mantle cell lymphoma (MCL), which had been biopsied elsewhere. The patient had no complaints, and his examination had unremarkable results. A magnetic resonance image of the head, performed as part of a full systemic work-up, revealed lacrimal sac and nasolacrimal duct thickening and opacification on both sides. A biopsy of the right lacrimal sac disclosed lymphocytes expressing CD20, CD5, B-cell lymphoma 2, cyclin D1, and SOX-11 proteins, yielding a diagnosis of bilateral MCL of the lacrimal system (Figure). Cases of MCL arise from pregerminal naive B cells expressing aberrant cyclin D1 resulting from the translocation t[11;14](q13;q32). 1 Bilateral involvement of the lacrimal sac and nasolacrimal duct is extremely rare. 2,3 This patient had only 1 additional neoplastic site (in his bone marrow). After chemotherapy with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-maxi-CHOP) with rituximab and high-dose cytarabine (R-HIDAC), he has been free of disease for 5 years.